{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:52Z","timestamp":1787026432177,"version":"build-2736575974"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Farnesoid X receptor (FXR) and Takeda G protein-coupled Receptor 5 (TGR5), the intestinal bile acid (BA) receptors, regulate the gut-derived hormones including fibroblast growth factor 15\/19 (FGF15\/19) and serotonin (5-hydrooxytryptamine, 5-HT). Here we show that ingestion of whey protein isolate, a milk protein, significantly decreased expression of heteromeric organic solute transporter Ost\u03b1 and Ost\u03b2, which is the basolateral BA transporter in the enterocyte, and increased the expression of FXR and FGF15 in C57BL6J mouse ileum and plasma FGF15 levels. In addition, the ingestion of whey protein isolate significantly suppressed expression of hepatic cholesterol-7\u03b1 hydroxylase (CYP7A1), which induces the primary BA synthesis, bile salt export pump (BSEP) and sodium-taurocholate cotransporting polypeptide (NTCP), which are the key transporters for the BA excretion and uptake in the liver, and genes involved in gluconeogenesis, and decreased the primary BAs including cholic acid, taurocholic acid, glycocholic acid, and taurochenodeoxycholic acid in the liver compared with controls. Moreover, ingestion of whey protein isolate significantly decreased the expression of TGR5, glucagon-like peptide 1 (GLP-1), and tryptophan hydroxylase1 (Tph1) in the small intestine, leading to decreases in plasma 5-HT and insulin levels. On the other hand, ingestion of the soy protein \u03b2-conglycinin significantly increased the expression of Ost\u03b1 and Ost\u03b2, and decreased the expression of FGF15 in the ileum and plasma FGF15 levels, leading to the increases in expression of hepatic CYP7A1, BSEP, NTCP, and genes involved in gluconeogenesis, and the primary BAs in the liver. Moreover, ingestion of \u03b2-conglycinin significantly increased the expression of intestinal TGR5, GLP-1, and Tph1, leading to increases in plasma 5-HT and insulin levels. These findings suggest that whey protein and \u03b2-conglycinin have opposite effects on intestinal FGF15 and 5-HT secretion in mice.<\/jats:p>","DOI":"10.3389\/fendo.2023.1080790","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:45:50Z","timestamp":1674780350000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Ingestion of whey protein and \u03b2-conglycinin exerts opposite effects on intestinal FGF15 and serotonin secretion in mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Katsunori","family":"Nonogaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu Rev Nut"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: The FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0074-3","article-title":"Metabolic messengers: fibroblast growth factor 15\/19","volume":"1","author":"Gadaleta","year":"2019","journal-title":"Nat Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.03.019","article-title":"FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1\u03b1 pathway","volume":"13","author":"Potthoff","year":"2011","journal-title":"Cell Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.5.8850","article-title":"Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity","volume":"143","author":"Tomlinson","year":"2002","journal-title":"Endocrinology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712328105","article-title":"The organic solute transporter \u03b1-\u03b2, ost\u03b1-ost\u03b2, is essential for intestinal bile acid transport and homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molmet.2018.03.004","article-title":"Enterochromaffin 5-HT cells- a major target for GLP-1 and gut microbial metabolites","volume":"11","author":"Lund","year":"2018","journal-title":"Mol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031600","article-title":"The regulatory role of the central and peripheral serotonin network on feeding signals in metabolic diseases","volume":"23","author":"Nonogaki","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15784","DOI":"10.1038\/s41598-020-72975-8","article-title":"Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet","volume":"10","author":"Nonogaki","year":"2020","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-1-14","article-title":"The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL\/6J mice","volume":"1","author":"de Wit","year":"2008","journal-title":"BMC Med Genomics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/srep28183","article-title":"Single ingestion of soy \u03b2-conglycinin induces increased postprandial circulating FGF21 levels exerting beneficial health effects","volume":"6","author":"Hashidume","year":"2016","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3766","article-title":"Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis","volume":"21","author":"Crane","year":"2015","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1038\/s41467-018-07287-7","article-title":"Serotonin signals through a gut-liver axis to regulate hepatic steatosis","volume":"9","author":"Choi","year":"2018","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2014.76","article-title":"Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients","volume":"39","author":"Gallego-Escuredo","year":"2015","journal-title":"Int J Obes"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20208","article-title":"Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects","volume":"21","author":"Haluz\u00edkov\u00e1","year":"2013","journal-title":"Obesity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2017.03.033","article-title":"Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content","volume":"13","author":"Fjeldborg","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dbi17-0007","article-title":"Targeting FXR and FGF19 to treat metabolic diseases lessons learned from bariatric surgery","volume":"67","author":"Bozadjieva","year":"2018","journal-title":"Diabetes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030645","article-title":"Fibroblast growth factor 19 and fibroblast growth factor 21 regulation in obese diabetics, and non-alcoholic fatty liver disease after gastric bypass","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.08.018","article-title":"Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC\u2013MS\/MS","volume":"873","author":"Alnouti","year":"2008","journal-title":"J Chromatogr B"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1080790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:45:53Z","timestamp":1674780353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1080790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":22,"alternative-id":["10.3389\/fendo.2023.1080790"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1080790","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"article-number":"1080790"}}